ACL.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 14, 2025

Report Source: 2025 Annual Report

Analyst's Ratings for Australian Clinical Labs Ltd (ACL.AX)

Based on 11 analysts giving stock ratings to Australian Clinical Labs Ltd in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
9
Buy
27
Hold
64
Sell
0
Strong Sell
0
Australian Clinical Labs Ltd

Australian Clinical Labs Ltd. Stock Analysis ACL.AX

Australia Health Care Micro Cap Report:
Australian Clinical Labs Ltd. engages in the provision of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. The company performs a range of services for doctors, patients and corporate clients, including chemical pathology, hematology, histopathology & cytopathology, serology & microbiology, allergy & immunology, molecular cancer testing, genetic carrier screening & other antenatal testing, cardiac testing services, veterinary pathology, functional pathology, and pathology services for clinical trials, among others. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. The company has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory. Its SunDoctors brand provides skin cancer care services.
Read More

Australian Clinical Labs Ltd (ACL.AX) Chart

Key Statistics of Australian Clinical Labs Ltd (ACL.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD1.85AUD1.90

Today's Open

AUD1.85

Volume

760.77K

P/E Ratio (TTM)

11.05

52 Week Range

AUD1.83AUD3.24

Market Cap

360.33M

Avg. Volume

333.50K

Dividend Yield

6.81%

Financial Metrics & Statements of Australian Clinical Labs Ltd (ACL.AX)

FAQ's for Australian Clinical Labs Ltd (ACL.AX)

  • According to Musaffa’s Shariah screening methodology, Australian Clinical Labs Ltd (ACL.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.